Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot Israel

Showing results (141-150 of 322) with videos related to

Pageof 33
Sort By:
American Journal of Respiratory and Critical Care Medicine|June 6, 2023
Reply to Lipworth and ChanChristopher S Ambrose, Elliot Israel, Karin Bowen, et al.
Journal of Asthma and Allergy|September 11, 2023
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATORTanya M Laidlaw, Andrew Menzies-Gow, Scott Caveney, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 3, 2015
Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood AsthmaWillem M C van Aalderen, Jonathan Grigg, Theresa W Guilbert, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2018
Association of free vitamin D<sub>3</sub> concentrations and asthma treatment failures in the VIDA TrialJohn J Lima, Mario Castro, Tonya S King, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2017
Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled CorticosteroidsTheresa W Guilbert, Gene Colice, Jonathan Grigg, et al.
The Journal of Allergy and Clinical Immunology|February 15, 2016
Vitamin D3 treatment of vitamin D-insufficient asthmatic patients does not alter immune cell functionBrandy Reid, Pierre-Olivier Girodet, Jonathan S Boomer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 27, 2024
Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma BiologicsArnaud Bourdin, Guy Brusselle, Simon Couillard, et al.
Nature Immunology|May 21, 2025
A single-cell spatial chart of the airway wall reveals proinflammatory cellular ecosystems and their interactions in health and asthmaRégis Joulia, Sara Patti, William J Traves, et al.
Chest|October 30, 2017
Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma ControlKelly Wong-McGrath, Loren C Denlinger, Eugene R Bleecker, et al.
The Lancet. Respiratory Medicine|January 26, 2023
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension studyAndrew Menzies-Gow, Michael E Wechsler, Christopher E Brightling, et al.
Pageof 33

Showing results (141-150 of 322) with videos related to

Sort By:
Pageof 33
American Journal of Respiratory and Critical Care Medicine|June 6, 2023
Reply to Lipworth and ChanChristopher S Ambrose, Elliot Israel, Karin Bowen, et al.
Journal of Asthma and Allergy|September 11, 2023
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATORTanya M Laidlaw, Andrew Menzies-Gow, Scott Caveney, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 3, 2015
Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood AsthmaWillem M C van Aalderen, Jonathan Grigg, Theresa W Guilbert, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 17, 2018
Association of free vitamin D<sub>3</sub> concentrations and asthma treatment failures in the VIDA TrialJohn J Lima, Mario Castro, Tonya S King, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 23, 2017
Real-Life Outcomes for Patients with Asthma Prescribed Spacers for Use with Either Extrafine- or Fine-Particle Inhaled CorticosteroidsTheresa W Guilbert, Gene Colice, Jonathan Grigg, et al.
The Journal of Allergy and Clinical Immunology|February 15, 2016
Vitamin D3 treatment of vitamin D-insufficient asthmatic patients does not alter immune cell functionBrandy Reid, Pierre-Olivier Girodet, Jonathan S Boomer, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 27, 2024
Phenotyping of Severe Asthma in the Era of Broad-Acting Anti-Asthma BiologicsArnaud Bourdin, Guy Brusselle, Simon Couillard, et al.
Nature Immunology|May 21, 2025
A single-cell spatial chart of the airway wall reveals proinflammatory cellular ecosystems and their interactions in health and asthmaRégis Joulia, Sara Patti, William J Traves, et al.
Chest|October 30, 2017
Internet-Based Monitoring in the Severe Asthma Research Program Identifies a Subgroup of Patients With Labile Asthma ControlKelly Wong-McGrath, Loren C Denlinger, Eugene R Bleecker, et al.
The Lancet. Respiratory Medicine|January 26, 2023
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension studyAndrew Menzies-Gow, Michael E Wechsler, Christopher E Brightling, et al.
Pageof 33